|
|
| TUESDAY,
JULY 9, 2002 |
| POSTER SESSION: OBESITY,
ADIPOSE TISSUE |
THE BENEFIT OF ORLISTAT ON WEIGHT AND LIPID PROFILE IN
OVERWEIGHT WOMEN
C. Petrogiannopoulos, S. Kalogeropoulos, G.S. Latsios,
G. Hartzoulakis, J. Vroulis,
A. Zaharof, Greece |
COMBINED
EFFECTS OF AN HMG COA REDUCTASE INHIBITOR AND FISH OIL
ON APOLIPOPROTEIN B-100 KINETICS IN VISCERAL OBESITY
D.C. Chan, G.F. Watts, P.H.R. Barrett, T.A. Mori,
L.J. Beilin, T.G. Redgrave, Australia |
PLASMA LIPID AND APOLIPOPROTEIN CHANGES AFTER WEIGHT LOSS
IN OBESE CHILDREN
A.Thaminy , B. Delplanque, B. Le Roy, A.
Ruelland, M-F. Rolland-Cachera, H. Thibault,
D. Soulié, P. Carbonel, M. Deheeger, P. Serog,
P. Boulos, France |
ABDOMINAL OBESITY IS CORRELATED WITH CHYLOMICRON LIPOLYSIS
IN NORMOLIPIDEMIC SUBJECTS
C. Vinagre, R.D. Santos, E. Ficker, A. Morikawa,
R. Maranhao, Brazil |
EFFECT OF THE -3826A/G VARIANT OF THE UNCOUPLING PROTEIN-1
GENE ON
OBESITY-RELATED PHENOTYPES IN A POPULATION-BASED STUDY
IN SPAIN
J.V.Sorli , D. Corella, M. Guillen, O. Portoles,
A. Sabater, J.I. Gonzalez, S. Ruiz De La Fuente,
D. Godoy, Spain |
THE ACUTE EFFECTS OF INSULIN ON CHYLOMICRON METABOLISM
IN VISCERALLY OBESE AND LEAN MEN
E.M. Allister, A.P. James, J.C.L. Mamo, P.H.R.
Barrett, M. Soares, G.F. Watts, Australia |
COMPARISON
BETWEEN DIET, ORLISTAT AND FLUVASTATIN IN OBESE PATIENTS
WITH MILD HYPERTENSION AND HYPERCHOLESTEROLEMIA
G. Derosa, A. Mugellini, L. Ciccarelli, G. Crescenzi,
M. Ghelfi, R. Fogari, Italy |
OBESE
CHILDREN HAVE HIGH ULTRASENSITIVE C-REACTIVE PROTEIN (HSCRP)
LEVELS
G. Holzer, M. Exner, H. Rumpold, K. Widhalm, B.
Jilma, O. Wagner, S. Kapiotis, Austria |
EVALUATION OF PARAMETERS OF ENDOTHELIAL FUNCTION IN BRACHIAL
ARTERIES AND IMT IN CAROTID ARTERIES IN CHILDREN WITH
OBESITY AND HYPERTENSION
J. Tolwinska, B. Glowinska, M. Urban, B. Pieciukiewicz,
Poland |
IS RISK FACTORS DISTRIBUTION DIFFERS, ACCORDING TO OBESITY
DEGREES IN PATIENTS WITH ANGIOGRAPHICALLY CONFIRMED CORONARY
ARTERY DISEASE?
K. Sonmez, M. Akcakoyun, A. Akcay, D. Demir, O.
Onat, M. Gencbay, M. Degertekin, F. Turan,
Turkey |
COMPARISON OF OBESITY PREVALANCE, BASED ON BODY MASS INDEX,
WAIST CIRCUMFERENCE AND WAIST/HIP RATIO, IN PATIENTS WITH
CORONARY ARTERY DISEASE (WHICH METHOD SHOULD BE USED?)
K. Sonmez, M. Akcakoyun, A. Akcay, D. Demir, O.H.
Elonu, O. Onat, R.B. Bakal, M. Gencbay,
M. Degertekin, F. Turan, Turkey |
POSTPRANDIAL CHANGES IN HDL COMPOSITION AT ABDOMINAL AND
GLUTEO-FEMORAL OBESITY
N.V. Perova, I.N. Ozerova, A.M. Olferiev, O.I.
Gorbatcheva, G.N. Shchukina, E.I. Sokolov,
Russia |
REPRODUCIBILITY
OF INTRAPERITONEAL AND RETROPERITONEAL FAT MEASUREMENT
BY COMPUTED TOMOGRAPHY
P. Von Hafe, A-M. Perez, P. Pinto, T. Jorge, P.
Froufe, M. Tavares, Portugal |
C-REACTIVE PROTEIN CONCENTRATION IS DECREASED BY WEIGHT
AND VISCERAL FAT REDUCTION
R. Poledne, A. Dvorakova, P. Suchanek, P. Stavek,
J. Tintera, Czech Republic |
LIPID PROFILE IN OBESE AND NON-OBESE GREEK HYPERTENSIVES
A.D. Efstratopoulos, S.M. Voyaki, S. Sasiakou,
A. Baltas, L. Mourgos, V. Lekakis, M. Pagoni, Greece |
INFLUENCE
OF WAIST TO HIP RATIO (WHR) ON DIURNAL TRIGLYCERIDE (TG)
PROFILES AS THE EXPRESSION OF POSTPRANDIAL LIPEMIA IN
FAMILIAL HYPERCHOLESTEROLEMIA
C. Gonzalez, A. Rodrigo, J.T. Real, M. Castro-Cabezas,
J.F. Ascaso, W. Erkelens,
R. Carmena, Spain, The Netherlands |
RANDOMIZED
CONTROLLED TRIAL OF THE EFFECT OF N-3 FATTY ACIDS SUPPLEMENTATION
ON APOLIPOPROTEIN B-100 AND CHYLOMICRON REMNANT METABOLISM
IN VISCERAL OBESITY
D.C. Chan, G.F. Watts, T.A. Mori, P.H.R. Barrett,
T.G. Redgrave, L.J. Beilin, Australia |
DEPENDENCE RISK FACTORS OF
ATHEROSCLEROSIS ON BODY MASS INDEX IN PATIENTS WITH DIABETES
MELLITUS TYPE 2
K. Yafasov, S. Ismailov, N. Sirojiddinova, N. Duyanskaya,
A. Averyanova, Uzbekistan |
POSTPRANDIAL HYPERLIPIDEMIA
IN OBESITY WITH AND WITHOUT TYPE 2 DIABETES IS DETERMINED
BY FASTING TRIGLYCERIDES AND CENTRAL OBESITY
J.P.H. Van Wijk, C.J.M. Halkes, D.W. Erkelens,
M. Castro Cabezas, The Netherlands |
THE TNF-ALPHA GENE NCO I POLYMORPHISM
AT POSITION-308 OF THE PROMOTER INFLUENCES INSULIN RESISTANCE,
AND INCREASED SERUM TRIGLICERIDES AFTER POSTPRANDIAL LIPAEMIA
IN FAMILIAR OBESITY
I. Wybranska, M. Malczewska-Malec, I. Leszynsa-Golabek,
A. Dembienska-Kiec, Poland |
THE ASSOCIATION BETWEEN ABDOMINAL
OBESITY, INFLAMMATORY MARKERS AND LIPID LEVELS, IN THE
GENERAL POPULATION: THE ATTICA STUDY
C. Chrysohoou, C. Pitsavos, J. Skoumas, D. Panagiotakos,
M.Toutouza, I. Papaioannou,
A. Zeimbekis, C. Stefanadis, P. Toutouzas, Greece |
RELATIONSHIPS OF BODY FAT
DISTRIBUTION, INSULIN SENSITIVITY AND CARDIOVASCULAR RISK
FACTORS IN NONOBESE, NONDIABETIC THAI SUBJECTS
C. Rattarasarn, R. Leelawattana, S. Soonthornpun,
W. Setasuban, A. Lim, A. Thamprasit,
W. Chayanunnukul, N. Thammakumpee, Thailand |
| POSTER SESSION: ENDOTHELIAL
DYSFUNCTION |
ENDOTHELIAL DYSFUNCTION AND POSTPRANDIAL LIPOPROTEINS
F.M. Maggi, S. Raselli, L. Grigore, L. Redaelli, S. Fantappie',
A.L. Catapano, Italy |
ENDOTHELIN-1 INVOLVED IN INFLAMMATORY RESPONSE IN ATHEROSCLEROSIS:
EVIDENCE OF ITS SWITCHING IN CYTOKINES AND SOLUBLE CELL
ADHESION MOLECULES PROINFLAMMATORY PROGRAMME
A.I. Teplyakov, Belarus |
POSTPRANDIAL RECRUITMENT OF NEUTROPHILS IS ASSOCIATED
TO ENDOTHELIAL DYSFUNCTION
A.J.H.H.M. Van Oostrom, E.J.P. De Koning, T.J.
Rabelink, M. Castro Cabezas,
The Netherlands |
CALCULATED
CARDIOVASCULAR RISK AND ENDOTHELIAL DYSFUNCTION
A.S. Wierzbicki, P.J. Chowienczyk, J.R. Cockcroft,
S.E. Brett, G.F. Watts, B.S. Jenkins,
J.M. Ritter, UK |
FUNCTIONAL AND BIOCHEMICAL CORRELATION BETWEEN ENDOTHELIAL
DYSFUNCTION AND INTIMA-MEDIA THICKNESS (IMT)
E. Bernal, A. Bajo-Martinez, A. Ugalde-Canitrot,
M. Calbacho, J. Haurie, C. Mendieta,
J. Saban, Spain |
INDUCTION
OF VASCULAR ENDOTHELIAL CELLS APOPTOSIS THROUGH THE PLATELET-ACTIVATING
FACTOR RECEPTOR IN HYPERCHOLESTEROLEMIA
C-H. Chen, T. Jiang, J-H. Yang, W. Jiang, H.J.
Pownall, C.M. Ballantyne, J. Lu, P.D. Henry,
C-Y. Yang, USA |
OXIDIZED LDL-INDUCED VASCULAR ENDOTHELIAL CELL APOPTOSIS
INVOLVES CERAMIDE-MEDIATED AKT DEPHOSPHORYLATION: PROTECTIVE
ROLE OF FGF2 OVEREXPRESSION
J. Lu, S. Suzuki, H.J. Safi, W. Jiang, P.D. Henry, J-H.
Yang, J.D. Morrisett, C-H. Chen, USA |
THE ANTIAPOPTOTIC EFFECT OF EXOGENOUS VEGF ON SERUM STARVED
ENDOTHELIAL CELLS IS MEDIATED VIA VEGFR-1 & VEGFR-2
C.W.M. Chan, C. Imray, A. Ahmed, UK |
NITRIC OXIDE RELEASE BY NITRATED LINOLEIC ACID PRODUCTS
E.S. Lima, P. DiMascio, F. Laurindo, H. Rubbo, D.S.P.
Abdalla, Brazil, Uruguay |
PPE-1-REGULATED ENDOTHELIAL-SPECIFIC GENE THERAPY USING
VEGF & PDGF-B INDUCED ANGIOGENESIS AND VESSEL MATURATION
IN ISCHEMIC LIMB MODEL
A. Shaish, K. Levanon, N. Vardr-Bloom, S. Greenberger,
I. Barshak, A. Orenstein, E. Breitbart,
D. Harats, Israel |
P38
MAPK DEPENDENT PATHWAY IS RESPONSIBLE FOR N-LDL AND OX-LDL
COX-2 INDUCTION IN HUMAN ENDOTHELIAL CELLS
G.D. Norata, A. Pirillo, F. Pellegatta, A.L. Catapano,
Italy |
THE
INFLUENCE OF LIPID-LOWERING TREATMENT ON NITRIC OXIDE
SYNTHESIS IN ENDOTHELIAL CELLS
I.V. Korzh, Ukraine |
ATORVASTATIN MODULATES VEGF AND VEGFR-2 EXPRESSION IN
APOLIPOPROTEIN E DEFICIENT MICE
M. Perez-Ilzarbe, B. Nespereira, P. Fernandez, J.A. Paramo,
J.A. Rodriguez, Spain |
THE
EFFECT OF CAFFEINE ON THE PERIPHERAL VASCULAR RESISTANCE
IN REGARD OF THE VASODILATATIVE MECHANISM OF ADENOSINE
M. Brodmann, U. Lischnigg, A. Lueger, E. Pilger,
G. Stark, Austria |
GENETIC
EVALUATION OF THE COMMON VARIANT OF THE ENDOTHELIAL NITRIC
OXIDE SYNTHASE (GLU298ASP) IN PATIENTS WITH THROMBANGITIS
OBLITERANS
M. Brodmann, W. Renner, G. Seinost, E. Pabst, G.
Stark, E. Pilger, Austria |
RELATIONSHIP BETWEEN ENDOTHELIAL NITRIC OXIDE SYNTHESIS
AND LOW-GRADE CHRONIC INFLAMMATION
O.M. Korzh, Ukraine |
ENDOTHELIAL DYSFUNCTION IN WORKERS EXPOSED TO LEAD
A. Skoczynska, R. Poreba, A. Derkacz, Poland |
INFLUENCE OF FIBRINOGEN AND HAEMORHEOLOGICAL FACTORS ON
ENDOTHELIAL FUNCTION IN HEALTHY WOMEN
S. Marchesi, A.R. Roscini, D. Siepi, R. Lombardini,
M. Pirro, L. Pasqualini, G. Vaudo,
G. Schillaci, G. Lupattelli, G Ciuffetti, E. Mannarino,
Italy |
MODULATION OF NO PRODUCTION BY OXLDL OF VARIOUS ORIGIN
IN HUVEC
A. Larbi, A. Khalil, T. Fulop, M. David-Dufilho,
A. Brunet, M-A. Devynck, Canada, France |
ELEVATED
PLASMA C-REACTIVE PROTEIN AND PROTEIN S, BUT NOT VON WILLEBRAND
FACTOR, V-CAM NOR P-SELECTIN LEVELS, ARE ASSOCIATED WITH
IMPAIRED ENDOTHELIUM DEPENDENT VASCULAR REACTIVITY IN
PATIENTS WITH CORONARY ARTERY DISEASE
R. Anderson, A. Dart, J.P.F. Chin-Dusting, Australia
|
INTIMA AS A BIOLOGICAL FILTER TO EXTRACELLULAR POOL OF
INTERNAL ENVIRONMENT OF THE BODY. PRIMARY AND SECONDARY
ATHEROMATOSIS
V.N. Titov, Russia |
SERUM
NON-ESTERIFIED VERY LONG-CHAIN PUFA ARE ASSOCIATED WITH
MARKERS OF ENDOTHELIAL DYSFUNCTION
P.Yli-Jama, I. Seljeflot, H.E. Meyer, E.M. Hjerkinn,
H. Arnesen, J.I. Pedersen Norway |
ROLE OF VARIOUS ADHESION AND ACTIVATION MOLECULES IN PATIENTS
WITH CORONARY ARTERY DISEASE
G.Dwivedi , R. Vijayvergiya, A. Grover, Y.P. Sharma,A.
Bhatnagar, S. Majumdar, India |
ROLE OF NITRIC OXIDE IN
PATIENTS WITH ESTABLISHED CORONARY ARTERY DISEASE
G.Dwivedi , R. Vijayvergiya, A. Grover, Y.P. Sharma,
A. Bhatnagar, S. Majumdar, India |
ENDOTHELIAL DYSFUNCTION APPEARS
EARLIER THAN SUCLINICAL ATHEROSCLEROSIS IN SYSTEM LUPUS
ERYTHEMATOUS (SLE)
P. Valdivielso, M. Haro, J.J. Gomez-Doblas, M.
Macias, A. Fernandez-Nebro,
P. Gonzalez-Santos, Spain |
ENDOTHELIAL DYSFUNCTION IN
MEMBERS OF FAMILIES WITH FAMILIAL COMBINED HYPERLIPIDEMIA
D. Karasek, H. Vaverkova, M. Hutyra, M. Halenka,
D. Novotny, L. Slavik, M. Budikova, Czech Republic |
| POSTER SESSION: LDL-APHERESIS
|
RESULTS OF LONG-TERM TREATMENT OF HOMOZYGOUS FAMILIAL
HYPERCHOLESTEROLEMIA (FH) CHILD WITH DEXTRAN SULPHATE
ADSORPTION. PORTUGUESE EXPERIENCE
E. Pedro, G. Ribeiro, P. Ramos, Z. Costa, A. Gaddi,
R. Fellin, M. Pais, S. Gomes, Portugal, Italy |
EFFICACY
OF A NEW PROTOCOL OF SELECTIVE APHERESIS IN INDUCING ATHEROSCLEROSIS
REGRESSION IN A CHILD WITH HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
T. Sampietro, M. Tuoni, B. Dal Pino, F. Bigazzi, M. Taddei,
A. Ciardi, E. Chella, S. Lusso,
A. Vallini, M.R. Puntoni, A. Bionda, Italy |
LONG TERM LIPID-APHERESIS IN TWO PATIENTS WITH MASSIVE
ELEVATION OF LIPOPROTEIN(A) AND PROGRESSIVE CORONARY HEART
DISEASE
A. Vogt, U. Kassner, H-P. Thomas, C. Schliesser,
E. Steinhagen-Thiessen, Germany |
H.E.L.P.
APHERESIS FOR THE TREATMENT OF ACUTE MYOCARDIAL INFARCTION
B.R. Jaeger, P. Uberfuhr, A. Knez, M. Oberhoffer,
A. Leber, B. Reichart, D. Seidel, Germany |
ACUTE EFFECTS OF CHOLESTEROL AND FIBRINOGEN REMOVAL ON
MYOCARDIAL VASOREACTIVITY IN HEART TRANSPLANT PATIENTS
B.R. Jaeger, F. Bengel, K. Odaka, P. Ueberfuhr,
E. Kreuzer, M. Schwaiger, B. Reichart,
D. Seidel, Germany |
SPECIFIC LP(A)-APHERESIS WITH IMMUNOADSORPTION - NEW TOOL
FOR THE TREATMENT OF SEVERE CHD PATIENTS WITH ELEVATED
LP(A)
S.N. Pokrovsky, O.I. Afanasieva, I.Y. Adamova, A.V. Sussekov,
V.V. Kukharchuk, S.G. Kipor, G.A. Konovalov, Russia
|
ONE YEAR OF EXPERIENCE WITH THE DALI LDL APHERESIS SYSTEM
R. Durst, D. Rund, D. Schurr, O. Eliav, D. Ben-Yehuda,
S. Shpizen, L. Ben-Avi, T. Schaap,
F. Pelz, E. Leiterdorf, Israel |
CHOLESTEROL
ABSORPTION AND BIOSYNTHESIS AFTER HYPOLIPIDEMIC INTERVENTION
BY LDL-APHERESIS
V. Blaha, R. Hyspler, M. Blaha, D. Solichova, P.
Zdansky, E. Havel, P. Vyroubal, Z. Zadak,
J. Maly, Czech Republic |
| POSTER SESSION: LIPOPROTEIN(a)
|
THE CHANGE OF COMPOSITION AS WELL AS THE CONCENTRATION
OF SERUM LP(A) CAN BE A SIGN FOR END-STAGE RENAL FAILURE
M. Kuboyama, M. Ageta, K. Nishihira, Y. Arimura,
T. Shigenaga, T. Ishihara, J-I. Ashitani,
Y. Fujiura, N. Kashio, I. Ikushima, Japan |
ACUTE PHASE REDUCTION OF LP(A) PREDICTS RESTENOSIS IN
PATIENTS WITH ACUTE MYOCARDIAL INFARCTION PERFORMED PRIMARY
PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY
A. Fujino, T. Watanabe, K. Taira, K. Ashikawa,
Y. Maruyama, Japan |
LIPOPROTEIN(A) AND BMI: SIGNIFICANT CORRELATION WITH POSITIVE
FAMILY HISTORY OF CARDIOVASCULAR DISEASES IN OBESE, HYPERTENSIVE
AND DIABETIC CHILDREN
B. Glowinska, M. Urban, A. Koput, Poland |
SIGHT
OF A PEAK IN THE TREATMENT OF SEVERE HYPERLIPOPROTEINEMIA(A)
[LP-(A)]
B.R. Jaeger, D. Seidel, Germany |
APOPROTEIN(A) PHENOTYPES AND LIPOPROTEIN(A) CONCENTRATION
IN PATIENTS WITH DIABETES MELLITUS
D.D. Labudovic, B.B. Todorova, K.N. Toseska, S.B.
Alabakovska, Macedonia |
LIPOPROTEIN
A AS AN INDEPENDENT RISK FACTOR FOR CORONARY ARTERY DISEASE
IN PATIENTS WITH ANGINA
E. Hatzinikolaou, G. Bobotis, A. Hotidis, I. Apostolou,
V. Tsiligaridis, D. Hatseras, Greece |
PLASMA
LP(A) LEVELS AND URINARY 8-ISOPROSTANE/PROSTAGLANDIN F2
ALPHA CONCENTRATIONS IN TRAINING ATHLETES
K. Makino, A. Katayama, I. Watanabe, Japan |
PLASMA
TFPI AND LP(A) LEVELS IN CORONARY ARTERY DISEASE
N. Domanic, D. Bilgen, H. Sonmez, C. Gurel, H.
Ekmekci, Z. Ozturk, A.S. Demir, T. Ulutin,
V.A. Vural, E. Kokoglu, Turkey |
EVIDENCE THAT A PROTEIN DISULPHIDE
ISOMERASE MAY PLAY A ROLE IN LIPOPROTEIN(A) ASSEMBLY
D. Callaghan, S.P.A McCormick, New Zealand |
MICROALBUMINURIA
AND PLASMA LIPOPROTEIN AND LP (A) LEVEL IN DIABETIC INDIVIDUALS
V.A. Tishchenko, T.B. Saburova, L.N. Kasina, N.V.
Gaidukova, Russia |
APOLIPOPROTEIN(A) ISOFORMS DISTRIBUTION IN MEN WITH ISCHEMIC
HEART DISEASE AND WITH GALLSTONE DISEASE (EPIDEMIOLOGICAL
STUDY)
Y.P. Nikitin, A.V. Tikhonov, I.N. Grigorieva, Russia
|
APO(A)
ISOFORMS AND SERUM LIPID LEVELS IN MEN WITH ISCHEMIC HEART
DISEASE AND WITH GALLSTONE DISEASE (EPIDEMIOLOGICAL STUDY)
Y.P. Nikitin, A.V. Tikhonov, I.N. Grigorieva, Russia
|
LIPOPROTEIN(A) IS ASSOCIATED WITH ANGIOGRAPHIC RESTENOSIS
AFTER CORONARY STENTING
M.V. Ezhov, Y.G. Matchin, A.P. Savchenko, O.I.
Afanasieva, T.Y. Polevaya, V.G. Naumov,
S.N. Pokrovsky, Russia |
LIPOPROTEIN(A) LEVELS AND
APOLIPOPROTEIN(A) ISOFORM SIZE IN PATIENTS WITH SUBCLINICAL
HYPOTHYROIDISM: EFFECT OF TREATMENT WITH L-THYROXINE
H. Milionis, Z. Efstathiadou, A. Tselepis, C. Tzallas,
E. Bairaktari, A. Tsatsouli, M. Elisaf, Greece |
| POSTER SESSION: OXIDATIVE
STRESS, ANTIOXIDANTS - SESSION I |
ROLE OF NEUTROPHILS IN OXIDIZED LDL MEDIATED INJURY OF
ENDOTHELIAL CELLS
K-J Chun, S-M. Son, I-J. Kim, T-J. Hong, Y-K. Kim,
Y-W. Shin, South Korea |
HIGH
DENSITY LIPOPROTEIN AND OXIDIZED LIPIDS AS THE MODULATORS
OF PLATELET RECEPTOR ACTIVITY
J. Hartwich, M. Motyka, A. Gruca, M. Bzowska, J. Skrzyczynska,
G. Schmitz, N. Leitinger,
A. Dembinska-Kiec, Poland, Germany, Austria |
ASSESSMENT OF ANTIOXIDATIVE BARRIER ENZYMES ACTIVITY DURING
FLUVASTATIN AND ATORVASTATIN THERAPY USED IN CORONARY
HEART DISEASE PRIMARY PROPHYLAXIS
J. Blaszczyk, J. Kowalski, L. Pawlicki, J. Grycewicz,
E. Rapacka, P. Kaczmarek, Poland |
THE
FAVOURABLE EFFECT OF CIPROFIBRATE ON THE OXIDISED LDL
CONCENTRATION, PARAOXONASE ACTIVITY AND ON THE LIPID PARAMETERS
IN PATIENTS WITH METABOLIC SYNDROME
G. Pados, M. Audikovszky, L. Debreczeni, L. Illyes,
I. Seres, G. Paragh, Hungary |
FREE
RADICAL-INDUCED MODIFICATION OF HUMAN FIBRINOGEN: IMPLICATIONS
FOR ATHEROSCLEROSIS
B. Lipinski, I. Lipinska, USA |
IRON AND FERRITIN LEVELS AND IRON/FERRITIN RATIO IN CORONARY
DISEASE PATIENTS
C. Holgado, T. Holgado, J. De La Vega, A. Aznar,
F. Fabiani, M.A. Rico, Spain |
ALTERATION IN ANTIOXIDANT CAPACITY IN CHRONIC RENAL FAILURE
AND HEMODIALYSIS PATIENTS: A POSSIBLE EXPLANATION FOR
THE INCREASED CARDIOVASCULAR RISK IN THESE PATIENTS
Z.G. Stojkova, S.A. Dzhekova-Stojkova, G.L. Bosilkova,
M.A. Krstevska, Macedonia |
OXYSTEROLS AS MARKERS OF ATHEROSCLEROSIS DEVELOPMENT
A.F. Safina, M.I. Dushkin, Y.S. Scwartz, Russia
|
PHYSICAL AND CHEMICAL INTERACTIONS OF OXIDIZED PHOSPHOLIPIDS
AFFECT GROWTH OF VASCULAR SMOOTH MUSCLE CELLS
A. Moumtzi, A. Hermetter, Austria |
INFLUENCE OF AN ANTIOXIDANT PROBUCOL IN A DOSEGE OF 250
MG/DAY ON THE FREQUENCY OF RESTENOSIS AFTER PERCUTANEOUS
TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA)
A. Kaminniy, V. Kukharchuk, V. Lankin, A. Samko,
Russia |
BIOLOGICALLY
ACTIVE PHOSPHOLIPIDS AND CERAMIDE: ROLE IN MMLDL-INDUCED
INTRACELLULAR SIGNALING OF SMOOTH MUSCLE CELLS
A. Loidl, R. Claus, H.P. Deigner, A. Hermetter,
Austria, Germany |
THE EFFECT OF A RESVERATROL-RICH WINE ON LDL OXIDATION
A.F. Revell, M. Legge, W.H.F. Sutherland, S.P.A.
McCormick, New Zealand |
DISTRIBUTION
OF ANTIBODIES AGAINST OXIDIZED LDL PLASMA LEVEL IN A WIDE
SAMPLE OF HEALTHY SUBJECTS: THE BRISIGHELLA HEART STUDY
A.F.G. Cicero, Z. Sangiorgi, M. Leoni, E. Grandi,
A. Dormi, A. Gaddi, Italy |
DIFFERENTIAL EFFECT OF OXIDATIVE AND NON-OXIDATIVE LIPID
METABOLISM ON ENDOTHELIN AND PAI-1 SERUM LEVELS IN A POPULATION
WITH ELEVATED CARDIOVASCULAR RISK
A. Ugalde-Canitrot, M. Calbacho, E. Bernal, A.
Bajo-Martinez, L. Gonzalez, R. Fabregate,
J. Saban, Spain |
CORRELATION BETWEEN SERUM LEVELS OF FERRITIN AND ALPHA-TOCOPHEROL
WITH THE DEGREE OF OXIDATIVE STRESS IN A POPULATION WITH
ELEVATED CARDIOVASCULAR RISK
M. Calbacho, A. Ugalde-Canitrot, A. Bajo-Martinez,
E. Bernal, B. Gonzalez, M. Diaz,
L. Gonzalez, R. Fabregate, J. Saban, Spain |
INFLUENCE OF EXERCISE TRAINING ON LDL METABOLISM AND LDL
OXIDATIVE PROCESS
C.G.C Vinagre, E. Ficker, C.E. Negrao, A.T. Morikawa,
M.J. Alves, M.U. Rondon,
R.C. Maranhao, Brazil |
ANTIOXIDANT ENZYMES ACTIVITIES IN PATIENTS WITH FAMILIAL
LCAT DEFICIENCY
B. Idzior Walus, T. Wesolowska, M. Walus, J. Sieradzki,
Poland |
PATHOPHYSIOLOGICAL
ROLE OF LIPID PEROXIDATION IN PATIENTS WITH ACUTE AND
CHRONIC CORONARY SYNDROMES
E. De Fanti, M. Rugolotto, A. Fasolin, E. Visentin,
M. Barbiero, G. Rigatelli, R. Schiavon, Italy |
RED
WINE POLYPHENOLICS INCREASE THE LOW DENSITY LIPOPROTEIN
RECEPTOR AND SUPPRESS THE SECRETION OF APOB100 IN HUMAN
HEPG2 CELLS
S. Pal, C. Sono, N. Ho, E. Allister, J. Mamo, Australia
|
NEUTROPHIL
SUPEROXIDE ANION GENERATION DURING ATORVASTATIN AND FLIVASTATIN
TREATMENT USED IN CORONARY HEART DISEASE PRIMARY PREVENTION
J. Kowalski, J. Kedziora, J. Blaszczyk, L Pawlicki,
J. Grycewicz, E. Rapacka, Poland |
OXIDATION MARKERS, TRADITIONAL
RISK FACTORS AND CARTOID ENLARGEMENT IN MIDDLE-AGED WOMEN
P.O. Rubba, A. Iannuzzi, M. De Michele, E. Celentano,
R. Tang, M.G. Bond, L. Sacchetti,
S. Panico, R. Galasso, M. Mercuri, Italy, USA |
STUDIES ON ANTIOXIDANT EFFECT OF SOME IRANIAN POPULAR
SPICES ON LDL OXIDATION
G.H. Naderi, M. Taher, S. Asgary, N. Sarafzadegan,
N. Nikkhoo, Iran |
ANTIOXIDANT EFFECTS OF SOME AMINO ACID ON LDL OXIDATION
G.H. Naderi, S. Asgary, N. Sarafzadegan, H. Shirvani,
Iran |
STUDY
ON ANTIOXIDANT EFFECT OF MELISSA OFFICINALIS BY HEPATOCYTS
OF RAT
G.H. Naderi, S. Asgary, E. Sajadi, R. Ziyaee, Iran
|
THE ANTIOXIDANT ACTIVITY OF THE ESSENTIAL OILS OF IRANIAN
CONIFERS ON RED BLOOD CELL
S. Asgary, M.R. Shams Ardekani, G.H. Naderi, A.
Emami, S. Aslani, S.H. Azali, Iran |
ANTIOXIDANT
EFFECT OF THE ESSENTIAL OILS OF LRANIAN CONIFERS AND VITAMIN
C ON LDL OXIDATION
S. Asgary, G.H. Naderi, A. Emami, M.R. Shams Ardekani,
T. Kesher, M. Gharipour, Iran |
IS THERE ANY DIFFERENCES BETWEEN THE LIPID PEROXIDATION
AND ANTI-OXIDANT CAPACITY BETWEENH ADDICT AND NON-ADDICT?
S. Asgary, G.H.A. Naderi, J. Sharezaei, P. Ahmadi,
Iran |
PEROXYNITRITE
AND MYOCARDIAL ADENOSINE PRODUCTION-PROTECTIVE EFFECT
OF MELATONIN
G. Kocic, R. Kocic, G. Bjelakovic, T. Jevtovic,
R. Pavlovic, D. Pavlovic, Yugoslavia |
INTENSIFICATION
OF LDL PEROXIDATION DURING THERAPY BY HMG-COA REDUCTASE
INHIBITORS
V. Lankin, A.K. Tikhaze, V.V. Kukharchuk, Russia
|
CLINICAL
USEFULNESS OF OXIDATIVE STRESS, ANTIOXIDATIVE AND LIPID
STATUS
N. Vrkic, E. Topic, V. Nikolic-Heitzler, N. Vukelic,
N. Zarkovic, H. Pintaric, Croatia |
THE
SUSCEPTIBILITY OF LDL TO OXIDATION BY MYELOPEROXIDASE
IS RELATED TO THE DIFFERENTIAL COUNT OF MONOCYTES
N. Moguilevsky, K. Zouaoui Boudjeltia, Y. Carpentier,
A. Bollen, D. Brohee,
M. Vanhaeverbeek, J. Ducobu, Belgium |
ATORVASTATIN
INCREASE IN LDL OXIDATION RESISTANCE IS INDEPENDENT OF
FAVOURABLE CHANGES IN LDL SIZE
J.M. Mostaza, R. Pena, J. Ordonez, C. Burgues,
J.L. Sanchez-Quesada, C. Lahoz, Spain |
THE EFFECT OF A LOW DOSE VITAMIN
E- VERSUS AN INCREASED DOSE POLYUNSATURATED FAT FROM CONCEPTION
ONWARDS ON ATHEROGENESIS IN LDLR-/- MICE
P.N. Demacker, P. Van Heijst, L.J. Van Tits, A.F.
Stalenhoef, The Netherlands |
FERRITIN, OXIDATIVE
STRESS AND CORONARY HEART DISEASE
P. Kraml, J. Potockova, H. Koprivova, S. Stipek,
J. Crkovska, T. Zima, M. Andel, Czech Republic |
THE RELATIONSHIP OF OXIDIZED
LOW DENSITY LIPPROTEINS (OX-LDL) TO CAROTID ARTERY INTIMA-MEDIA
THCIKNESS (IMT) AND OTHER SELECTED BIOCHEMICAL AND CLINICAL
RISK FACTORS OF ATHEROSCLEROSIS
M. Hutyra, H. Vaverkova, N. Dalibor, K. David,
H. Milan, Czech Republic |
AUTOANTBODIES AGAINST OXIDIZED
LDL AND BIOACTIVE PHOSPHOLIPIDS FORMED DURING OXIDATION
IN PATIENTS WITH CORONARY ARTERY DISEASE
E.S. Lourida, A.I. Papathanasiou, L.D. Tsironis,
J.A. Goudevenos, M. Elisaf, D.A. Siderls,
A.D. Tselepis, Greece |
| POSTER SESSION: THROMBOTIC
AND HEMOSTATIC RISK FACTORS IN ATHEROSCLEROSIS
|
COMBINED EFFECT OF CHONDROITIN SULFATE-MODIFIED SUPEROXIDE
DISMUTASE AND CATALASE IN ANTITHROMBOTIC PROTECTION OF
VASCULAR WALL
A.V. Maksimenko, V.L. Golubykh, E.G. Tischenko,
Russia |
POSTOPERATIVE LOWERING OF PLASMA FIBRINOGEN AND LDL BY
APHERESIS FOR THE PREVENTION OF EARLY GRAFT CLOSURE AFTER
CORONARY BYPASS GRAFTING
B.R. Jaeger, M. Oberhoffer, E. Kreuzer, F. Blessing,
J. Schirmer, T. Kauke, B. Reichart,
D. Seidel, Germany |
PLASMA
D-DIMER LEVEL AND RISK OF CORONARY ARTERY DISEASE
N. Domanic, B. Karadag, Turkey |
THE
INFLUENCE OF TISSUE PLASMINOGEN ACTIVATOR ON THE LEVELS
OF MATRIX METALLOPROTEINASES AND THEIR INHIBITOR. ASSOCIATION
BETWEEN PROTEOLYTIC AND FIBRINOLYTIC MECHANISM DURING
A MYOCARDIAL INFARCTION
D. Tziakas, G. Chalikias, E. Hatzinikolaou, E.
Papadopoulos, G. Trypsianis,
E. Papadopoulou, D. Floros, I. Tentes, E. Kontoleon-Bakalopoulou,
D. Hatseras, Greece |
ACTIVATION OF THROMBIN AND FIBRINOLYTIC SYSTEMS AFTER
THROMBOLYSIS IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION
G.S. Latsios, A.T. Anastasopoulou, N.V. Michalopoulos,
A. Papanikitas, E. Dimoula,
A.G. Georgoulas, A. Zaharof, Greece |
SEVERITY
AND EXTENSION OF CORONARY ARTERY DISEASE IN ASSOCIATION
TO PLASMA FIBRINOGEN LEVELS
G.S. Latsios, A.T. Anastasopoulou, N.V. Michalopoulos,
A. Papanikitas, G. Svoukas,
A.G. Georgoulas, A. Zaharof, Greece |
PLASMA
UROKINASE AS PREDICTOR OF RECURRENT ANGINA AFTER CORONARY
ANGIOPLASTY
I. Alekseeva, Y. Parfyonova, A. Lyakishev, A. Dobrovolsky,
Z. Gabbasov, V. Naumov, Russia |
LONG-TERM EFFECTS OF SIMVASTATIN ON EXTRINSIC COAGULATION
PATHWAY, THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR-TAFI
AND OTHER HEMOSTATIC PARAMETERS IN CAPD PATIENTS
J. Malyszko, J.S. Malyszko, T. Hryszko, M. Mysliwiec,
Poland |
STUDY ON POSSIBLE CORRELATIONS BETWEEN COAGULATION-RELATED
SINGLE NUCLEOTID POLYMORPHISMS IN PATIENTS WITH VENOUS
AND ARTERIAL THROMBOEMBOLISM
L. Mark, J. Marki-Zay, V. Hanyecz, G. Simondan,
I. Hajdara, A. Katona, Hungary |
PLASMA FIBRINOLYTIC CAPACITY IN POSTMENOPAUSAL WOMEN IS
RELATED WITH THE DIFFERENTIATION STATE OF BLOOD MONOCYTES
K. Zouaoui Boudjeltia, M. Guillaume, C. Gregoir,
C. Remacle, P. Piro, P. Cuchie,
M. Vanhaeverbeek, J. Ducobu, D. Brohee, Belgium |
PLATELET
AND PLASMINOGEN SYSTEM ACTIVITY IN PATIENTS WITH DIFFERENT
CHARACTERISTICS OF ACUTE CORONARY SYNDROME
O.R. Dotsenko, V.Z. Netiazhenko, I.V. Melnik, T.V.
Kozmyk, Ukraine |
RELATIONSHIP
BETWEEN MAJOR HEMOSTASIS PARAMETERS AND METABOLIC SYNDROME
COMPONENTS IN MEN WITH MODERATE ARTERIAL HYPERTENSION
V.A. Metelskaya, L.A. Ratnikova, M.N. Mamedov,
A.M. Olferiev, I.E. Petrichenko, N.V. Perova, Russia |
THE EFFECT OF OPIUM ADDICTION ON THE PLASMA LEVELS OF
FIBRINOGEN FACTOR VII AND CRP
G.H. Naderi, S. Asgary, A. Dehghani, S.H. Azali,
M. Gharipour, Iran |
THE
FUNCTIONAL STATE OF THE HEMOSTASIS SYSTEM IN TRAUMATOLOGIC
AND ORTHOPEDIC PATIENTS WITH ATHEROSCLEROSIS
G.V. Korshunov, D.M. Puchinyan, A.G. Korshunov,
L.O. Khvichiya, I.V. Matasova,
S.I. Yaroshevskaya, S.G. Shahmartova, Russia |
PERICELLULAR PLASMIN INDUCES SMOOTH MUSCLE CELL ANOIKIS
O. Meilhac, B. Ho-Tin-Noe, E. Angles-Cano, M. Philippe,
J-B. Michel, France |
PLATELET
ACTIVATION IN UNSTABLE ANGINA IN HIGH AND LOW CLINICAL
RISK OF UNFAVORABLE OUTCOME PATIENT POPULATION
V.Z. Netiazhenk, O.R. Dotsenko, O.M. Plenova, Ukraine
|
|
IS THE FACTOR XIII 34VAL/LEU POLYMORPHISM A PROTECTIVE
FACTOR FOR CEREBROVASCULAR DISEASE?
G. Endler, M. Funk, D. Haering, W. Lalouschek,
W. Lang, M. Mirafzal, O. Wagner,
C. Mannhgalter, Austria
|
EVALUATION OF GENDER DIFFERENCES
IN THROMBOTIC RISK FACTORS DURNG LIPID LOWERING THERAPY
WITH ATORVASTATIN
E. Hatzinikolaou, K. Klebetsanis, D. Tziakas, I. Papadopoulos,
T. Iosifidis, G. Halikias,
D. Hatseras, Greece |
A POSSIBLE PREDICTIVE ROLE
FOR VASCULAR EVENTS OF PLATELET ACTIVATING FACTOR-ACETYLHYDROLAZE
(PAF-AH) AND ANTIPHOSPHOLIPID ANTIBODIES (APLA) IN PATIENTS
WITH CORONARY ATHEROSCLEROSIS
C. Tanaseanu, E. Moldoveanu, T. Kosaka, S. Tanaseanu,
M. Popescu, D. Hanganu,
I. Tamsulea, Romania, Japan |
| POSTER SESSION: HYPERTENSION
|
PREVALENCE
OF DYSLIPIDAEMIA IN PATIENTS WITH ESSENTIAL HYPERTENSION
J.A. Papadakis, G. Vrentzos, A. Kalikaki, G. Perisinaki,
S. Kois, E.S. Ganotakis, Greece |
EFFECT
OF BLOOD LIPOPROTEINS ON CONTRACTILE FUNCTION OF VESSELS
IN RATS
O.K. Kulchitsky, S.N. Novikova, N.V. Sikalo, Ukraine
|
CIRCADIAN VARIATION OF SILENT MYOCARDIAL ISCHEMIA IN HYPERTENSIVES
AND ITS ELECTROCARDIOGRAPHIC FEATURES IN A 24 HOUR HOLTER
MONITORING
C.A.T. Ibanez, R.E. Ramboyong, E.S. Caguioa, D.R.
Flores Jr., R.V. Anastacio, Philippines |
ATTENUATION OF CIRCADIAN BLOOD PRESSURE RHYTHM IS INDEPENDENT
DETERMINANT OF DEVELOPMENT OF ATHEROSCLEROSIS IN HYPERTENSION
T.M. Ripp, S.E. Pekarski, V.F. Mordovin, S.V. Triss,
Russia |
EFFECTS
OF SIMVASTATIN 40 MG ON BLOOD PRESSURE IN HYPERCHOLESTEROLEMIC
PATIENTS
A. Branchi, A.M. Fiorenza, A. Torri, C. Berra,
E. Colombo, A. Rovellini, D. Sommariva, Italy |
MUTATIONS IN THE ANGIOTENSINOGEN GENE, ELEVATED BLOOD
PRESSURE, AND RISK OF ISCHEMIC HEART- AND CEREBROVASCULAR
DISEASE. THE COPENHAGEN CITY HEART STUDY
A.A Sethi, B.G. Nordestgaard, M-L.M. Graenholdt, R. Steffensen,
G.B. Jensen,
A. Tybjaerg-Hansen, Denmark |
THE
INFLUENCE OF ANALISED HYPERTENSIVE DRUGS ON PULSE PRESSURE
IN PATIENTS WITH MILD-TO-MODERATE ESSENTIAL HYPERTENSION
A. Miczke, M. Cymerys, W. Bryl, M. Luczak, D. Pupek-Musialik,
Poland |
BLOOD PRESSURE AND DIABETES, HOW THEY RUN IN AN OUTPATIENT
DIABETIC CLINIC
E. Llargues, E. Deig, A. Recasens, I. Castells,
V. Yetano, S. Montull, Spain |
EFFECTS OF ANTIHYPERTENSIVE AND HYPOLIPIDEMIC DRUGS ON
PLASMA AND HDL-ASSOCIATED PAF-ACETYLHYDROLASE ACTIVITY
E. Rizos, V. Tsimihodimos, A. Tambaki, A. Kakafika,
A. Tselepis, J. Goudevenos,
C. Siamopoulos, M. Elisaf, Greece |
ALTERED EXPRESSION OF INTERMEDIATE CONDUCTANCE CALCIUM-ACTIVATED
POTASSIUM CHANNELS INDUCED BY LONG-TERM BLOCKADE OF NITRIC
OXIDE SYNTHESIS
H. Hasegawa, T. Saito, Y. Chiba, Y. Fujiwara, A.
Shoji, H. Miura, M. Miura, Japan, USA |
HYPOLIPIDEMIC
EFFECT OF LACIPIL IN HYPERTENSIVES WITH HEART FAILURE
I.G. Alizade, N.T. Karaeva, Azerbaijan |
MEMBRANE
PROTECTIVE EFFECT OF PRESTARIUM IN HYPERTENSIVES WITH
HEART FAILURE
I.G. Alizade, N.T. Karaeva, Azerbaijan |
PRITOR
IN THE TREATMENT OF PATIENTS WITH HYPERTENSION AND OBESITY
I.G. Alizade, N.T. Karaeva, Azerbaijan |
AUTONOMIC NERVOUS SYSTEM INFLUENCE ON PULSE PRESSURE IN
MILD NON-TREATED HYPERTENSION
J. Freitas, R. Santos, M. Carvalho, A. Falcao De
Freitas, Portugal |
INFLUENCE
OF BETA 2 AND BETA 3 RECEPTORS GENE POLYMORPHISM ON CARDIOVASCULAR
RISK: A CASE-CONTROL STUDY
L. Forga, M. Corbalan, M. Palacios, A. Rivero,
A. Marti, J.A. Martinez, Spain |
CARDIOVASCULAR
REACTIVITY TO MENTAL STRESS TEST, AUTONOMIC BALANCE AND
BAROREFLEX SENSITIVITY IN HYPERTENSIVE PATIENTS
L. Guasti, D. Zanotta, L.T. Mainardi, C. Simoni,
D. Garganico, C. Crespi, G. Gaudio,
A. Maffiolini, A.M. Grandi, S. Cerutti, A. Venco, Italy
|
EFFECTIVENESS OF ACTION ON PREVENTION IN THE SOUTHERN
POLAND EPIDEMIOLOGIC SURVEY. DISTRIBUTION OF BLOOD PRESSURE
IN RELATION TO AGE AND GENDER
K. Kozakiewicz, M. Sosnowski, T. Pawlowski, K.
Zaorski, P. Garbocz, M. Tendera, Poland |
THE EVALUATION OF THE NO-INDEPENDENT VASODILATATIVE EFFECT
OF ILOPROST IN ISOLATED PERFUSED GUINEA PIG HIND LIMBS
M. Brodmann, U. Lischnigg, A. Lueger, E. Pilger,
G. Stark, Austria |
HYPERTENSION,
POSTPRANDIAL LIPEMIA AND GENE POLYMORPHISM IN OBESE FAMILIES
M. Malczewska-Malec, M. Kwasniak, A. Zdzienicka,
B. Kiec-Wilk, I. Wybranska, M. Szopa,
A. Dembinska-Kiec, Poland |
SUPPRESSION
OF RENIN-ANGIOTENSIN SYSTEM (RAS) CAN REDUCE PLASMINOGEN
ACTIVATOR INHIBITOR-1 (PAI-1) PRODUCTION IN ENDOTHERIAL
CELLS STIMULATED BY CHYROMICRON REMNANTS (CR)
S. Morimoto, Y. Fujioka, S. Tsuboi, Y. Naito, D.
Kawasaki, T. Okumura, M. Masai, T. Sakoda,
T. Tsujino, T. Iwasaki, H. Hosoai, Japan |
GOOD CORRELATION BETWEEN AORTIC FUNCTION INDICES AND TARGET
ORGAN DAMAGE IN UNTREATED HYPERTENSION
W-C. Tsai, Y-Y. Huang, T-H. Chao, P-Y. Liu, J-H.
Chen, Taiwan |
THE INFLUENCE OF ANALISED HYPERTENSIVE DRUGS ON PULSE
PRESSURE IN PATIENTS WITH MILD-TO-MODERATE ESSENTIAL HYPERTENSION
W. Bryl, A. Miczke, P. Bogdanski, M. Luczak, M.
Cymerys, D. Pupek-Musialik, Poland |
GROWTH HORMONE COULD HAVE A ROLE IN ESSENTIAL HYPERTENSION.
ITS RELATIONSHIP WITH CIRCADIAN BLOOD PRESSURE PROFILE
AND INSULIN RESISTANCE
C.A. Feldstein, D. Garrido, M. Akopian, A. Renauld,
A.O. Olivieri, A. Zavala, Argentina |
EFFECT OF COMBINED HYPOTENSIVE AND HYPOLIPIDEMIC THERAPY
ON CHD METABOLIC RISK FACTORS IN NIDDM PATIENTS
L. Khadipash, M. Mamedov, O. Kosmatova, N. Perova,
Russia |
THE USEFULNESS OF WEIGHT LOSS IN LOWERING BLOOD PRESSURE
P. Marks, UK |
HEART RATE VARIABILITY IN SYSTEMIC SCLEROSIS. THE INFLUENCE
OF PULMONARY HYPERTENSION
I. Moyssakis, N.J. Pantazopoulos, Y. Hallaq, P.
Vlachoyannopoulos, V. Vassiliou, V. Votteas, Greece |
DIETARY SODIUM CHLORIDE RESTRICTION RAISES THE PLASMA
LIPID CONCENTRATION IN MICE KNOCKOUT FOR THE APOE AND
FOR THE LDL RECEPTOR GENE
S.Catanozi , J.C. Rocha, M. Passarelli, M.L. Guzzo,
C. Alves, L.N.S. Furukawa, T. Brito,
E.R. Nakandakare, J.C. Heimann, E.C.R. Quintao,
Brazil |
RELATIONSHIP BETWEEN HIGH LDL AND PERSISTENT HYPERTENSION
D. Gavish, E. Leibovitz, D. Dicker, Y. Yosefi,
R.J. Viskoper, Israel |
PREVALENCE OF HYPERTENSION
AND OBESITY IN IRAN
F. Jalali, Iran |
THE ANGIOTENSIN-CONVERTING-ENZYME
INSERTION/DELETION POLYMORPHISM IS NOT A RISK FACTOR FOR
PERIPHERAL ARTERIAL DISEASE
W. Renner, E. Pabst, B. Paulweber, L. Malaimare,
B. Iglseder, T.C. Wascher, E. Pilger, Austria |
| POSTER SESSION: STATINS
- SESSION II |
POSSIBLE
INFLUENCE OF STATINS ON THE PARAOXONASE ACTIVITY
D. Muacevic-Katanec, V. Bradamante, Z. Reiner,
M. Sucic, Z. Metelko, Croatia |
INFLUENCE
OF ATORVASTATIN ON LDL-SUBTYPES IN PATIENTS WITH HYPERTRIGLYCERIDEMIA
H.C. Geiss, E. Laubach, P. Schwandt, K.G. Parhofer,
Germany |
ROSUVASTATIN REDUCES PLASMA TOTAL CHOLESTEROL AND TRIGLYCERIDE
LEVELS BY INHIBITION OF VLDL-PRODUCTION IN FEMALE APOE*3-LEIDEN
TRANSGENIC MICE
D.J.M. Delsing, S.M. Post, H. Van Der Boom, W. Van Duyvenvoorde,
E.C.M. De Wit,
V.W. Bloks, F. Kuipers, L.M. Havekes, H.M.G. Princen,
The Netherlands |
CONTRIBUTION OF APO CIII REDUCTION TO THE GREATER EFFECT
OF MICRONIZED FENOFIBRATE THAN ATORVASTATIN ON TRIGLYCERIDE
LEVELS AND LDL SIZE IN DYSLIPIDEMIC PATIENTS UNDER TREATMENT
FOR 12 WEEKS
I. Lemieux, J-P. Despres, The Study Groups, H.
Salomon, Canada, France |
NEW INSIGHT INTO NON-STATIN PREVENTION AND TREATMENT OF
ATHEROSCLEROSIS
I.A. Sobenin, A.N. Orekhov, Russia |
SAFETY OF ROSUVASTATIN IN PATIENTS DEVELOPING LDL-C <80
MG/DL AND <50 MG/DL IN CLINICAL TRIALS
J. Shepherd, I. Carbarns, S. Harris, R. Caplan,
J. Pears, UK, USA |
EVALUATION OF ROSUVASTATIN IN THE TREATMENT OF HYPERCHOLESTEROLAEMIA
IN POSTMENOPAUSAL WOMEN
J. Shepherd, C. Packard, K. Smith, D. Kallend,
UK |
EFFECT OF ATORVASTATIN ON APOB-48 METABOLISM AND LDL-RECEPTOR
EXPRESSION IN NORMOLIPIDAEMIC SUBJECTS WITH CORONARY ARTERY
DISEASE
C. Dane-Stewart, G.F. Watts, S. Pal, R. Taylor, P. Thompson,
J. Hung, J.C. Mamo, Australia |
MEASURING EFFECTS ON INTIMA MEDIA THICKNESS: AN EVALUATION
OF ROSUVASTATIN - THE METEOR STUDY
J.R. Crouse, D.E. Grobbee, D.H. O'Leary, J.J.P.
Kastelein, M.L. Bots, G.W. Evans,
M.K. Palmer, J.S. Raichlen, USA, The Netherlands, UK |
BENEFICIAL EFFECTS OF STATINS IN VESSEL DISEASE PROGRESS
AFTER CABG REGARDLESS OF CHOLESTEROL LOWERING
P. Kaperneka, J. Malakos, G. Kolovou, G. Hatzigeorgiou,
K. Sorontila, A. Michalis,
D. Daskalova, D.V. Cokkinos, Greece |
ATORVASTATIN
IMPROVES POSTPRANDIAL LIPOPROTEIN METABOLISM IN HYPERTRIGLYCERIDEMIA
K.G. Parhofer, E. Laubach, P.H.R. Barrett, Germany,
Australia |
ATORVASTATIN LIMITS THE PROINFLAMMATORY RESPONSE OF SMOOTH
MUSCLE CELL TO THROMBIN
M. Haloui, O. Meilhac, H. Laouenan, J-B. Michel,
France |
LEUKOCYTE EXPRESSION OF CELL ADHESION MOLECULES IN PATIENTS
WITH HYPERCHOLESTEROLEMIA: EFFECTS OF ATORVASTATIN TREATMENT
T. Stulc, M. Vrablik, I. Marinov, Z. Kasalova,
R. Ceska, Czech Republic |
THE HYPOTRIGLYCERIDEMIC EFFECT OF PRAVASTATIN IS ASSOCIATED
WITH A DECREASE IN SERUM APO-E CONCENTRATION IN OUR HYPERLIPEMIC
POPULATION
M. De Oya, I. Campo, E. Viturro, B. Cano, M. Benavente,
R. Rubio, C. Garces, Spain |
EFFECTS OF ATORVASTATIN ON MICROVASCULAR REACTIVITY IN
PATIENTS WITH HYPERCHOLESTEROLEMIA
Z. Kasalova ,T. Stulc, M. Vrablik, M. Prazny,
J. Skrha, R. Ceska, Czech Republic |
SIMVASTATIN REDUCES THE LEVELS OF APO E-CONTAINING TRIGLYCERIDE-RICH
LIPOPROTEINS IN MEN WITH PREMATURE CORONARY ARTERY DISEASE
M. Rizzo, C.M. Barbagallo, V. Pernice, A. Pace,
A.B. Cefalu', A. Rubino, D. Pieri, A. Frasheri,
A. Notarbartolo, M.R. Averna, Italy |
SAFETY AND EFFICACY OF LONG-TERM COMBINED STATIN-FIBRATE
TREATMENT FOR SEVERE MIXED HYPERLIPIDAEMIA
M. Zeman, T. Vareka, S. Romaniv, A. Zak, Czech
Republic |
ROSUVASTATIN IS MORE EFFECTIVE THAN ATORVASTATIN IN MODIFYING
LIPID PROFILES AND ACHIEVING NATIONAL CHOLESTEROL EDUCATION
PROGRAM ADULT TREATMENT PANEL III LDL-CHOLESTEROL GOALS
O. Wiklund, M. Davidson, R. Chitra, H. Hutchinson,
A. Raza, Sweden, USA |
EFFECT OF LOW DOSE SIMVASTATIN ON CAROTID ATHEROSCLEROSIS
PROGRESSION IN NIDDM PATIENTS WITH HYPERLIPIDAEMIA(A)
N.V. Dubyanskaya, K.M. Yafasov, N.Z. Sirojiddinova,
Uzbekistan |
THE HMG-COA REDUCTASE INHIBITORS PREVENTS AT1 RECEPTOR
GENE OVEREXPRESSION IN HUMAN VASCULAR SMOOTH MUSCLE CELLS
AND ENDOTHELIAL CELLS STIMULATED WITH KAPPA-ELASTIN
T.M. Francuz, E. Kotrys-Puchalska, T. Jurczak,
T. Gawlik, J.G. Gminski, Poland |
EFFECT OF ATORVASTATIN ON SERUM URIC ACID AND CREATININE
LEVELS
V. Tsimihodimos, A. Kakafika, G. Liamis, G. Miltiadous,
H. Milionis, E. Bairaktari,
C. Seferiades, M. Elisaf, Greece |
GENE
EXPRESSION PROFILING IN CLINICAL BLOOD SAMPLES: THE STATIN
PILOT STUDY
V. Wibaut-Berlaimont, V. Mandryko, R. Naoumova,
D. Haskard, A. Randi, UK |
HETEROZYGOUS
FAMILIAL HYPERCHOLESTEROLEMIA: COADMINISTRATION OF EZETIMIBE
PLUS ATORVASTATIN
W. Vermaak, X. Pinto, D. Ponsonnet, P. Sager, L.
Lipka, R. Suresh, E. Veltri, South Africa, USA |
ATORVASTATIN REDUCES APOE AND APOC-1 SYNTHESIS AND SECRETION
IN THP-1 MACROPHAGES
L. Nassi Castilho, A. Chamberland, L. Boulet, J.
Davignon, J.S. Cohn, L. Bernier, Canada |
PLAQUE
STABILIZATION EFFECTS OF THE ATORVASTATINE
N. Kipshidze, N. Kakauridze, Georgia |
| POSTER SESSION: VARIA
|
'QUIT AND WIN' AS MUCH CLOSE, BEST OUTCOMES
E. Llargues, E. Deig, R. Martinez, J. Isidro, T.
Rodellar, R. Fito, F. Balaguer, R. Velayos, Spain |
IS
LIFETIME TOBACCO SMOKING ASSOCIATED WITH ATHEROSCLEROSIS
AND ARTERIAL STIFFNESS IN 36-YEAR OLD MEN AND WOMEN? THE
AMSTERDAM GROWTH AND HEALTH LONGITUDINAL STUDY
E.H.C.M. Bekkering, C.M. Bernaards, J.W.R. Twisk,
C.D.A. Stehouwer, W. Van Mechelen,
H.C.G. Kemper, The Netherlands |
SMOKING AND ATHEROSCLEROSIS
Z.A. Velija-Asimi, A. Strika, K. Krijestarac, A.
Begovic, Bosnia Herzegovina |
GENERATION OF APOE2- AND APOE4-SECRETING CELL LINES BY
TARGETING OF WILD-TYPE APOE3 CELLS USING IN-SITU CHIMERAPLASTY
Z. Mohri, A.D. Tagalakis, G. Dickson, J.S. Owen,
UK |
HUMAN BLOOD PLASMA TRANS-SIALIDASE CAUSES ATHEROGENIC
MODIFICATION OF LDL
I.A. Sobenin, I.V. Suprun, T.A. Skalbe, A.N. Orekhov,
Russia |
A FLOW CYTOMETRIC PROCEDURE TO MEASURE FUNCTIONAL LDL
RECEPTORS FOR DIAGNOSIS OF FAMILIAL HYPECHOLESTEROLEMIA
H. Hattori, M. Nagano, K. Kawamura, J. Ishii, M.
Tsuji, F. Iwata, T. Yamamura, Y. Miyake,
T. Egashira, T. Okada, N.E. Miller, M. Emi, A. Yamamoto,
Japan, UK, |
APOLIPOPROTEIN
A5 POLYMORPHISMS AND PLASMA LEVELS OF TRIGLYCERIDES
J.A. Hubacek, V. Adamkova, V. Lanska, R. Poledne,
Czech Republic |
EFFECTS
OF THE THYROID RECEPTOR-BETA AGONIST, GC-1, ON CHOLESTEROL
AND TRIGLYCERIDE METABOLISM IN INTACT MALE MICE
L. Johansson, B. Angelin, M. Rudling, T. Scanlan,
J. Baxter, P. Parini, Sweden, USA |
EFFECTS OF MODERATE PHYSICAL TRAINING ON ENDOTHELIUM-DEPENDENT
DILATATION IN PATIENTS WITH RECENT MYOCARDIAL INFARCTION
M. Vona, A. Rossi, S. Rizzo, G. Pinna, F. Cobelli,
Italy |
REGULATION OF LIPID AND LIPOPROTEIN METABOLISM BY THE
PITUITARY: GROWTH HORMONE SPECIFIC EFFECTS AND RELATIVE
IMPORTANCE OF PROLACTIN
M. Matasconi, M. Rudling, B. Angelin, Sweden |
NUCLEAR 3-PHOSPHOINOSITIDE METABOLISM AND VASCULAR SMOOTH
MUSCLE CELLS PROLIFERATION
P. Déléris, D. Bacqueville, B. Perret,
M. Breton-Douillon, France |
LIPID
PROFILE AND PSA IN ADULT MEN
S. Paximadas, S. Pagoni, A. Efstratopoulos, K.
Kanellas, P. Nikitopoulou, G. Papageorgiou, Greece |
LDL-CHOLESTEROL MODULATES THE MEMBRANE BINDING AND INTRACELLULAR
DISTRIBUTION OF ANNEXIN 6 IN CHO CELLS
F. Schwartz, P. Dauterstedt, I. De Diego, J. Heeren, U.
Beisiegel, C. Enrich, T. Grewal, Germany, Spain
|
IS ANTIPHOSPHOLIPID ANTIBODIES A RISK FACTOR FOR ATHEROSCLEROSIS?
T. Reshetnyak, T. Popkova, T. Tichonova, L. Patrushev,
T. Kovalenko, E. Match, I. Oserova,
N. Perova, O Fomicheva, E. Alexandrova, V. Nassonova,
E. Nassonov, Russia |
CIRCULATING
CELL ADHESION MOLECULES IN DEPENDENCE ON AGE AND CARDIOVASCULAR
RISK
V. Richter, F. Rassoul, K. Purschwitz, B. Hentschel,
W. Reuter, T. Kuntze, B. Kloetzer, Germany |
INFLUENCE OF CHRONIC CIGARETTE SMOKING ON THE POSTPRANDIAL
CHANGES OF SERUM LIPID PROFILE
I.V. Medvedeva, T.A. Pugacheva, I.F. Sholomov,
A.A. Pushnikov, E.F. Odishev, Russia |
AORTIC DISTENSIBILTY IN SICKLE CELL THALASSAEMIA
I. Moyssakis, N.J. Pantazopoulos, P. Tsaftaridis,
Y. Hallaq, P. Gioldasis, V. Votteas, Greece |
BIOCHEMICAL
CHANGES IN IN-SITU CARDIAC MYOCYTES AT DIFFERENT STAGES
OF ISCHEMIC PRECONDITIONING IN RABBIT MODEL
A. Grover, R. Vijayvergiya, D. Sharma, S. Majumdar,
V.K. Bhargava, India |
THE ACUTE EFFECT OF ETHANOL EXPOSURE ON HDL CHOLESTEROL
Y. Neumark ,Y. Friedlander, R. Durst, D.
Jaffe, E. Butbul, E. Leitersdorf, Israel |
STEM
CELLS AND PATHOGENESIS OF HUMAN ATHEROSCLEROSIS
E.L.Soboleva, O.S. Saburova, R.S. Akchurin, E.I. Chazov,
V.N. Smirnov, Russia |
TRANSVASCULAR LOW DENSITY
LIPOPROTEIN TRANSPORT IN PATIENTS WITH DIABETES MELLITUS
(TYPE 2): A NON-INVASIVE IN VIVO ISOTOPE TECHNIQUE
K. Kornerup, B.G. Nordestgaard, B. Feldt-Rasmussen,
K. Borch-Johnsen, K.S. Jensen,
J.S. Jensen, Denmark |
|
| | |
